Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acoustic neurinoma
acoustic neurinoma, bilateral
acquired immunodeficiency syndrome
adrenoleukodystrophy
advances in neurology
adverse drug reaction
Alexanders disease
algorithm
Alzheimer's disease
Alzheimer's disease, familial
amniocentesis
amyloid angiopathy, cerebral
amyloid angiopathy, hereditary cystatin C
attention deficit disorder with hyperactivity
audiogram
auditory evoked brainstem potentials
basal ganglia, degeneration
basal ganglia, lesion of
Bassen-Kornzweig syndrome
brain biopsy
brainstem, lesion of
bulbar palsy, progressive
calcification, intracranial
CAT scan, emission
CAT scan, emission, abnormal
cataracts
cerebellar lesion
cerebro hepato renal syndrome
cerebrovascular accident
cerebrovascular accident, familial occurrence
cerebrovascular accident, young adult
Charcot-Marie-Tooth
children
chromosomal abnormality
chromosome 17
chromosome 22
chromosome 9
Cockayne's syndrome
cost effectiveness
creatine phosphokinase(CPK)elevated
cryptococcal meningitis
cytomegalovirus infection
dentate nuclei
dentate nuclei, lesion of
DNA probes
drug induced neurologic disorders
dystonia
dystonia musculorum deformens
dystrophin
ear, abnormal
electronystagmography
electroretinograph
encephalitis
encephalitis, focal
encephalitis, Rasmussen's
encephalitis, viral
enzyme, muscle disease
ependymoma
face, elongated
facial appearance, abnormal
familial
fasciculation
fragile-X syndrome
fundus, abnormality of
gadolinium
gene
gene mutation
genetic counselling
genetic diagnosis, prenatal
genetic linkage
genetic neurologic disorders
genetic screening
genetic testing
gynecomastia
Hallervorden Spatz disease
hearing loss
hemiparesis
hepatolenticular degeneration(Wilson's disease)
Huntington's chorea
Huntington's chorea, genetic counselling
Huntington's chorea, late onset
Huntington's chorea, presymptomatic detection of
Huntington's disease, children
hyperactivity
imbalance
immunohistochemistry
immunoperoxidase staining
in situ hybridization
inclusion bodies, intracytopasmic
intracerebral hemorrhage
intracerebral hemorrhage, familial
intracerebral hemorrhage, young adult
joint hypermobility
Kearns-Sayre syndrome
Kugelberg-Welander syndrome
Laurence-Moon-Bardet-Biedl syndrome
leukodystrophy
leukoencephalopathy
macular degeneration
manic-depressive
meningioma
meningitis
meningitis, recurrent
meningitis, relapse
mental retardation
mental retardation, familial
misdiagnosis
molecular genetics
mongolism
motor neuron disease
MRI
MRI, abnormal
MRI, contrast enhanced
mucopolysaccharidoses
muscle biopsy
muscular dystrophy
muscular dystrophy, Becker
muscular dystrophy, differential diagnosis of
muscular dystrophy, Duchenne
muscular dystrophy, Duchenne, carrier
muscular dystrophy, Duchenne, neonatal screening
muscular dystrophy, Duchenne, presymptomatic detection
muscular dystrophy, female occurrence of
muscular dystrophy, limb-girdle
myopathy, mitochondrial
myopia
myotonia dystrophica
neonatal screening, genetic neurologic disorders
neoplasm, intracranial
neoplasm, intracranial, multiple
neoplasm, primary of CNS
neoplasm, primary of CNS-multiple
nerve growth factor
neurofibromatosis 1
neurofibromatosis 2
neurofibromatosis 2, presymptomatic
neurologic disease
neurologic disease, diagnoses of
neuronal ceroid-lipofuscinosis
neuropathology
neuropathy
neuropathy, amyloid
neuropathy, hereditary peripheral
neuropathy, peripheral
neurotransmitter
night blindness
optic atrophy
optic nerve
optic neuropathy
patient information and support
peptides, brain
peroxisomal disease
pigmentary retinopathy
polymerase chain reaction
polyneuropathy, familial
posterior fossa, lesion of
pregnancy, neurologic complications in
prenatal diagnosis by amniocentesis
prognosis
progressive multifocal leucoencephalopathy
progressive spinal muscular atrophy
psychological testing
psychological testing, neurologic problems
recombinant DNA
recurrent
refractive errors
Refsum's disease
retinal degeneration
retinal lesion
retinitis pigmentosa
retinopathy
review article
RFLPs
Rosenthal fibers
seizure
seizure, focal
seizure, intractable, treatment of
sensorineural hearing loss
simian crease
somatostatin
Southern immunoblot test
spinal muscular atrophy
spinocerebellar degeneration
tapetoretinal degeneration
testicular enlargement
tinnitus
treatment of neurologic disorder
Usher's syndrome
viral infection
viral infection, CNS
visual field defect
visual loss
visuospatial disturbance
Von Hippel Lindau
Von Hippel Lindau, carrier
Von Hippel Lindau, screening protocol for
Western immunoblot test
white matter disease
Wood's light
X-linked bulbospinal neuronopathy
X-linked neuropathy
Showing articles 350 to 400 of 885 << Previous Next >>

Usefulness of Checking Platelet Count Before Thrombolysis in Acute Ischemic Stroke
Stroke 38:1639-1640, Cucchiara,B.L.,et al, 2007

Magnetic Resonance Perfusion Diffusion Mismatch and Thrombolysis in Acute Ischaemic Stroke: A Systematic Review of the Evidence to Date
JNNP 78:485-491,443, Kane,I.,et al, 2007

Thrombolysis for Ischemic Stroke in Children. Data From the Natioinwide Inpatient Sample
Stroke 38:1850-1854,1722, Janjua,N.,et al, 2007

Evaluation of the Clinical-Diffusion and Perfusion-Diffusion Mismatch Models in DEFUSE
Stroke 38:1826-1830,1718, Lansberg,M.G.,et al, 2007

Estimated Cost Savings of Increased Use of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Canada
Storke 38:1952-1955,1732, Yip,T.R. &Demaerschalk,B.M., 2007

Intra-arterial Therapies for Acute Ischemic Stroke
Neurol 68:2132-2139, Mandava,P. &Kent,T.A., 2007

Consent for Intravenous Thrombolysis in Acute Stroke
Arch Neurol 64:785-792, White-Bateman,S.R.,et al, 2007

Multiple Ischemic Strokes Associated With Use of Recombinant Activated Factor VII
Arch Neurol 64:879-881, Libman,R.B.,et al, 2007

Hemorrhage After Thrombolytic Therapy for Stroke: The Clinically Relevant Number Needed to Harm
Stroke 38:2279-2283, Saver,J.L., 2007

Acute Ischemic Stroke
NEJM 357:572-529, Bart van der Worp,H. &van Gijn,J., 2007

Randomized Trial of Intraarterial Infusion of Urokinase Within 6 Hours of Middle Cerebral Artery Stroke: The Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan
Stroke 38:2633-2639,2627, Ogawa,A.,et al, 2007

Prediction of Hemorrhagic Transformation After Recanalization Therapy Using T2*-Permeability Magnetic Resonance Imaging
Ann Neurol 62:170-176, Bang,O.Y.,et al, 2007

Bleeding Risk Analysis in Stroke Imaging Before ThromboLysis (BRASIL): Pooled Analysis of T2*-Weighted Magnetic Resonance Imaging Data From 570 Patients
Storke 38:2738-2744, Fiehler,J.,et al, 2007

MRI-Based and CT-Based Thrombolytic Therapy in Acute Stroke Within and Beyond Established Time Windows
Stroke 38:2640-2645, Schellinger,P.D.,et al, 2007

Intravenous Alteplase for Stroke: Beyond the Guidelines and in Particular Clinical Situations
Stroke 38:2612-2618, De Keyser,J.,et al, 2007

Long-Term Outcome After Thrombolysis in Telemedical Stroke Care
Neurol 69:898-903,819, Schwab,S.,et al, 2007

Intratumoral Hemorrhage After Thrombolsyis in a Patient With Glioblastoma Multiforme
Neurol 69:936, Grimm,S.A. &DeAngelis,L.M., 2007

Anterior Cerebral Artery Emboli in Combined Intravenous and Intra-arterial rtPA Treatment of Acute Ischemic Stroke in the IMS I and II Trials
AJNR 28:1890-1894, King,S.,et al, 2007

Population-Based Analysis of the Impact of Expanding the Time Window for Acute Stroke Treatment
Stroke 38:3213-3217, Juhl,J.,et al, 2007

Recanalization After Thrombolysis in Stroke Patients: Predictors and Prognostic Implications
Neurol 68:39-44, Zangerle,A.,et al, 2007

Hemostatic Drug Therapies for Acute, Nontraumatic Intracerebral Hemorrhage
Stroke 38:204-205, Al-Shahi,R. &You,H., 2007

Cost-Effectiveness of Intravenous Thrombolysis With Alteplase Within a 3-Hour Window After Acute Ischemic Stroke
Stroke 38:85-89, Ehlers,L.,et al, 2007

Is Intra-Arterial Thrombolysis Safe After Full-Dose Intravenous Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke?
Stroke 38:80-84, Shaltoni,H.M.,et al, 2007

Asymptomatic Hemorrhage After Thrombolysis May Not Be Benign: Prognosis by Hemorrhage Type in the Canadian Alteplase for Stroke Effectiveness Study Registry
Stroke 38:7579, Dzialowski,I.,et al, 2007

Established Treatments for Acute Ischaemic Stroke
Lancet 369:319-330, Khaja,A.M. &Grotta,J.C., 2007

Thrombolysis With Alteplase for Acute Ischaemic Stroke in the Safe Implementation of Thrombolysis in stroke-Monitoring Study (SITS-MOST): An Observational Study
Lancet 369:275-282,249, Wahlgren,N.,et al, 2007

Ischemic and Hemorrhagic Complications After Intra-Arterial Fibrinolysis in Vertebrobasilar Occlusion
AJNR 28:378-381, Schulte-Altedorneburg,G.,et al, 2007

Identification of the Penumbra and Infarct Core on Hyperacute Noncontrast and Perfusion CT
Neurol 68:730-736,717, Parsons,M.W.,et al, 2007

Comparison of CT Perfusion and Angiography and MRI in Selecting Stroke Patients for Acute Treatment
Neurol 68:694-697, Wintermark,M.,et al, 2007

The Safety of Hospital Stroke Care
Neurol 68:550-555,542, Holloway,R.G.,et al, 2007

Perioperative Stroke
NEJM 356:706-713, Selim,M., 2007

Leukoaraiosis and Intracerebral Hemorrhage After Thrombolysis in Acute Stroke
Neurol 68:1020-1024, Palumbo,V.,et al, 2007

Admission Facility Is Associated With Outcome of Basilar Artery Occlusion
Stroke 38:1380-1383, Muller,R.,et al, 2007

Urgent Clinical Challenges in Children With Ischemic Stroke
Stroke 37:116-122,3, Kuhle,S.,et al, 2006

Perfusion CT Helps Decision Making for Thrombolysis When There is No Clear Time of Onset
JNNP 77:417-419, Hellier,K.D.,et al, 2006

Thrombolysis for Acute Stroke with Special Emphasis on the Very Old:Experience From a Single Dutch Centre
JNNP 77:375-377,288, van Oostenbrugge,R.J.,et al, 2006

Alexander Disease, Ventricular Garlands and Abnormalities of the Medulla and Spinal Cord
Neurol 66:494-498,468, van der Knaap,M.S.,et al, 2006

Outcome and Symptomatic Bleeding Complications of Intravenous Thrombolysis Within 6 Hours in MRI-Selected Stroke Patients
Stroke 37:852-858, Thomalla,G.,et al, 2006

Role of CT Angiography in Thrombolysis Decision-Making for Patients with Presumed Seizure at Stroke Onset
Stroke 37:915-917, Sylaja,P.N.,et al, 2006

Therapy of Basilar Artery Occlusion, A Systematic Analysis Comparing Intra-Arterial and Intravenous Thrombolysis
Stroke 37:922-928, Lindsberg,P.J.&Mattle,H.P., 2006

Thrombolytic Therapy of Acute Ischemic Stroke During Pregnancy
Neurol 66:768-770, Murugappan,A.,et al, 2006

Extent of Early Ischemic Changes on Computed Tomgraphy (CT) Before Thrombolysis
Stroke 37:973-978, Dzialowski,I.,et al, 2006

Imaging-Guided Acute Ischemic Stroke Therapy: From "Time is Brain" to "Physiology is Brain"
AJNR 27:728-735, Gonzalez,R.G., 2006

Poststroke C-Reactive Protein Is a Powerful Prognostic Tool Among Candidates for Thrombolysis
Stroke 37:1205-1210, Montaner,J.,et al, 2006

Good Outcomes in Ischemic Stroke Patients treated With Intravenous Thrombolysis Despite Regressing Neurological Symptoms
Stroke 37:1332-1333, Baumann,C.R.,et al, 2006

Is IV Tissue Plasminogen Activator Beneficial in Patients With Hyperdense Artery Sign?
Neurol 66:1171-1174, Qureshi,A.I.,et al, 2006

Reasons Why Few Patients With Acute Stroke Receive Tissue Plasminogen Activator
Arch Neurol 63:661-664, Bambauer,K.Z.,et al, 2006

Clinicopath Conf, Acute Ischemic Stroke
NEJM 354:2263-2271, Case 16:2006, 2006

Thrombolysis in Patients Older Than 80 Years With Acute Ischaemic Stroke: Canadian Alteplase for Stroke Effectiveness Study
JNNP 77:826-829,812, Sylaja, P.N.,et al, 2006

Safety of Mechanical Thrombectomy and Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke: Results of the Multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) Trial, Part I
AJNR 27:1177-1182, W.S. Smith, for the Multi MERCI Investigators, 2006



Showing articles 350 to 400 of 885 << Previous Next >>